Taysha Gene Therapies Inc [TSHA] Stock sold by Insider Nagendran Sukumar for $0.16 million

Taysha Gene Therapies Inc’s filing revealed that its President and Head of R&D Nagendran Sukumar unloaded Company’s shares for reported $0.16 million on Aug 21 ’25. In the deal valued at $2.85 per share,57,054 shares were sold. As a result of this transaction, Nagendran Sukumar now holds 1,165,289 shares worth roughly $3.4 million.

Then, Alam Kamran sold 54,491 shares, generating $155,299 in total proceeds. Upon selling the shares at $2.85, the CHIEF FINANCIAL OFFICER now owns 1,187,603 shares.

Before that, Kamran Alam bought 54,491 shares. Taysha Gene Therapies Inc shares valued at $156,389 were divested by the Officer at a price of $2.87 per share.

BofA Securities initiated its Taysha Gene Therapies Inc [TSHA] rating to a Buy in a research note published on July 11, 2025; the price target was $8. A number of analysts have revised their coverage, including BMO Capital Markets’s analysts, who began to cover the stock in late June with a ‘”an Outperform”‘ rating. Piper Sandler began covering TSHA with “an Overweight” recommendation on April 09, 2024. Jefferies revised its rating on February 01, 2023. It rated TSHA as “a Hold” which previously was an “a Buy”.

Price Performance Review of TSHA

On Monday, Taysha Gene Therapies Inc [NASDAQ:TSHA] saw its stock fall -2.67% to $2.92. Over the last five days, the stock has lost -0.34%. Taysha Gene Therapies Inc shares have risen nearly 29.20% since the year began. Nevertheless, the stocks have risen 68.79% over the past one year. While a 52-week high of $3.31 was reached on 05/21/25, a 52-week low of $1.05 was recorded on 04/09/25.

Levels Of Support And Resistance For TSHA Stock

The 24-hour chart illustrates a support level at 2.85, which if violated will result in even more drops to 2.79. On the upside, there is a resistance level at 3.04. A further resistance level may holdings at 3.16.

How much short interest is there in Taysha Gene Therapies Inc?

A steep rise in short interest was recorded in Taysha Gene Therapies Inc stocks on 2025-07-31, dropping by -1.64 million shares to a total of 38.21 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 39.85 million shares. There was a decline of -4.3%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.